Hao Haisheng's expected performance has fallen sharply, with a profit of 65 million to 78 million yuan in the semi -annual profit of 2022

On July 29, 2022, the A-share listed company Hao Haisheng (code: 688366.SH) released the semi-annual report performance forecast. For 10,000 to 78 million yuan, net profit decreased by 71.86%year -on -year to 66.24%.

The company makes the above prediction based on the following reasons:

(1) Since February 2022, Shanghai and surrounding cities have experienced severe. The production of the company and three subsidiaries in Shanghai has been significantly affected. Until the slowdown of June, Shanghai has successively lifted static management, and the company's production has been able to. Gradually recover. Although the company actively organizes production and shipping on the basis of doing a good job, minimizes the impact as much as possible, and strives to make up for it in June, compared with the same period last year, the operating income of the company and Shanghai subsidiaries is still relatively compared to compared The decline in the same period last year, the loss of gross profit brought by it exceeded RMB 90 million;

(2) In the same period last year, the company received a dividend of Shenwu 1 investment product dividend of about RMB 25.69 million. During the reporting period, no such dividend income was received;

(3) During the reporting period, the company's US subsidiary Aarenscientificinc. The layer believes that the AAREN business has signs of impairment and an impairment test. According to the results of the impairment test, the amount of asset impairment of AAREN business and intangible assets for AAREN business will be lost by about RMB 25 million;

(4) During the reporting period, due to the implementation of the equity incentive plan, the company and some subsidiaries have amortized for about RMB 15 million in stock. This fee does not exist in the same period last year.

Haohai Biology, the company's full name Shanghai Haohai Biotechnology Co., Ltd., was established on January 24, 2007. The current general manager Wu Jianying. Production and sales.

- END -